GSLI Lumonics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : GSLI Lumonics

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BMcV who wrote (303)	10/3/2000 4:38:45 PM
From: Ram Seetharaman	Read Replies (1) of 328

Morning Comments from Chase H&Q 10/3/00 9:10:44 AM Source: Chase H&Q San Francisco, CA, October 3, 2000, 9:15 PST * GSI Lumonics (GSLI) $15.06 - $622MM mkt cap: Completes Optics Acquisition; Reiterate BUY on Weakness Analyst: Joseph T. Arsenio (415) 439-3339 GSLI recently closed its cash acquisition of a California-based optics business on Sept 21st, that specializes in supplying products to the semiconductor, aerospace and defense industries. GSLI also completed its divestiture of its Life Sciences unit for $40 million in cash and 4.6 million in Packard Bioscience common stock. We expect GSLI to meet our F3Q revenue and earnings estimates of $92.3M and $0.14/sh. Longer-term, we expect approximately 8-10% of FY01 revenues from GSI's optics business with improving operating margins. Believe the accelerating telecom optics outlook and short-term stock price weakness provides a significant buying opportunity.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next